Daewoong Pharmaceutical’s “‘Hoystar tablet’ could not meet the main evaluation variable in phase 2a clinical trial for corona treatment”
Daewoong Pharmaceutical’s Hoy Star tablet phase 2a main evaluation variable not satisfied…2b/3 phase progress
Daewoong Pharmaceutical confirms the treatment effect of COVID-19 in Hoystar tablet ‘2a clinical trial’
Daewoong Pharmaceutical confirms the effect of Hoystar tablet COVID-19 treatment in Phase 2a clinical trial
Daewoong Pharmaceutical’s’Hoystar tablet’ confirmed the possibility of COVID-19 treatment in phase 2a clinical trial
![[CES 2021]Micro LED in the home, rollable in hand… Display evolution](https://img.etnews.com/2017/img/facebookblank.png "[CES 2021]Micro LED in the home, rollable in hand… Display evolution")
